1. Introduction {#sec1-molecules-23-00235}
===============

Heterocyclic compounds are important because of their presence in a broad range of natural products and synthetic organic molecules with various biological activities \[[@B1-molecules-23-00235],[@B2-molecules-23-00235]\]. Coumarin scaffolds are commonly found in diverse natural products, biologically active compounds and pharmaceuticals \[[@B3-molecules-23-00235],[@B4-molecules-23-00235]\]. Among the various coumarin derivatives, substituted 4-hydroxycoumarin derivatives are of much importance because they exist in many natural products and exhibit a wide range of biological activities such as anti-HIV \[[@B5-molecules-23-00235]\], anticancer \[[@B6-molecules-23-00235]\], anti-coagulant \[[@B7-molecules-23-00235]\] and antioxidant \[[@B8-molecules-23-00235]\] activities. Warfarin I and coumatetralyl II are used for pesticides, specifically as a rodenticide and anticoagulant \[[@B9-molecules-23-00235]\]. ([Figure 1](#molecules-23-00235-f001){ref-type="fig"})

The development of a simple and eco-friendly protocol for the construction of heterocycles libraries of medical motifs is an attractive area of research in both academia and the pharmaceutical industry. Multicomponent reactions (MCRs) are promising and powerful tools in organic, combinatorial, and medicinal chemistry, because of their atom economy, complexity and diversity of products, multiple bond formation efficiency, and environmental friendliness \[[@B10-molecules-23-00235]\]. These features make MCRs suitable for the easy construction of complex heterocyclic scaffolds from readily available starting materials \[[@B11-molecules-23-00235]\]. In the past decade, some MCRs have been used for the construction of 4-hydroxycoumarin derivatives \[[@B12-molecules-23-00235],[@B13-molecules-23-00235],[@B14-molecules-23-00235],[@B15-molecules-23-00235],[@B16-molecules-23-00235]\].

Microwave irradiation has been increasingly used in organic synthesis in recent years. Compared with traditional methods, this method has the advantages of higher yields, shorter reaction time, mild reaction conditions and environmentally friendliness. To date, a large number of organic reactions can be carried out under microwave irradiation conditions \[[@B17-molecules-23-00235],[@B18-molecules-23-00235],[@B19-molecules-23-00235],[@B20-molecules-23-00235]\].

The development of environmentally friendly synthetic methods is a challenge in modern organic synthesis. The need to reduce the amount of toxic waste and byproducts arising from chemical processes has resulted in an increasing emphasis on the use of less-toxic and environmentally compatible materials in the design of new synthetic methods. Traditional purification methods such as recrystallization and column chromatography have problems in terms of consumption of organic solvents and energy, waste generation, and pollution. The concept of group-assisted purification (GAP) techniques, which avoid traditional crystallization and chromatographic purification methods and reduce waste generation from silica and solvents, particularly toxic solvents, was first developed by Li's group in the design of asymmetric synthesis of new imine reagents \[[@B21-molecules-23-00235],[@B22-molecules-23-00235]\]. To date, GAP chemistry has been used in many asymmetric reactions \[[@B23-molecules-23-00235],[@B24-molecules-23-00235],[@B25-molecules-23-00235]\] and MCRs \[[@B26-molecules-23-00235],[@B27-molecules-23-00235],[@B28-molecules-23-00235]\]. As part of our current studies on the development of environmentally friendly routes to heterocyclic compounds \[[@B29-molecules-23-00235],[@B30-molecules-23-00235],[@B31-molecules-23-00235],[@B32-molecules-23-00235]\], we now report an efficient and clean synthesis of 3-functionalized 4-hydroxycoumarin derivatives under catalyst-free conditions.

2. Results and Discussion {#sec2-molecules-23-00235}
=========================

We initially evaluated the three-component reaction of a 1:1:1 mixture of 4-hydroxycoumarin (**1**), phenylglyoxal monohydrate (**2a**) and 3-(*p*-tolylamino)cyclopent-2-enone (**3a**) for the optimization of the reaction conditions. The results are summarized in [Table 1](#molecules-23-00235-t001){ref-type="table"}. The desired product **4a** was obtained in 89% yield when the reaction was carried out in ethanol at 100 °C for 30 min. under catalyst-free and microwave irradiation conditions ([Table 1](#molecules-23-00235-t001){ref-type="table"}, entry 1). Various solvents were then evaluated to determine the impact of the solvent on the yield. Of all the solvents tested, i.e., anhydrous ethanol, water, DMF, acetonitrile, and a mixture of anhydrous ethanol-water (1:1 and 3:1, *v*/*v*), ethanol gave the best result ([Table 1](#molecules-23-00235-t001){ref-type="table"}, entries 1--6). To improve the yield, several catalysts were evaluated: sodium hydrate, diethyl amine, *p*-toluenesulfonic acid (*p*-TSA), benzoic acid and *L*-proline ([Table 1](#molecules-23-00235-t001){ref-type="table"}, entries 7--11). The results revealed that none of the catalysts could catalyze this reaction. The reaction was then conducted at different temperatures, such as 80, 90, 100 and 110 °C, to determine the optimum temperature for this transformation. All of these experiments were conducted in ethanol under catalyst-free and microwave irradiation conditions, and the desired product **4a** was obtained in yields of 69%, 76%, 89% and 87%, respectively ([Table 1](#molecules-23-00235-t001){ref-type="table"}, entries 1 and 12--14). Finally, the reaction was performed at different reaction times to determine the optimum reaction time. The results showed that the best reaction time was 30 min ([Table 1](#molecules-23-00235-t001){ref-type="table"}, entries 1 and 15--17). When the reaction was carried out in ethanol at refluxing temperature for 4 h in the absence of microwave, the desired product was obtained in 60% yield ([Table 1](#molecules-23-00235-t001){ref-type="table"}, entry 18). These indicate that the microwave irradiation can improve the yield and shorten the reaction times. Accordingly, the best temperature for this transformation was 100 °C. On the basis of all of these experiments, the optimum reaction conditions were identified as ethanol at 100 °C for 30 min. under catalyst-free and microwave irradiation conditions.

With optimal conditions in hand, various substituted phenylglyoxal monohydrate (**2**) and 3-arylaminocyclopent-2-enone (**3**) were explored to investigate the generality of this three- component reaction for the synthesis of 3-functionalized 4-hydroxycoumarin derivatives (**4**). The results are tabulated in [Table 2](#molecules-23-00235-t002){ref-type="table"}. The reaction seemed to be tolerant of substitution of the phenylglyoxal and 3-arylaminocyclopent-2-enone with either electron-withdrawing or electron-donating groups. Overall, yields in the range of 70%--95% were obtained.

To our delight, under optimal conditions, further experiments showed that when the 3-arylaminocyclopent-2-enone (**3**) was replaced by 4-arylaminofuran-2(5*H*)-one (**5**), the corresponding 3-functionalized 4-hydroxycoumarin derivatives (**6**) were obtained in good yields ([Table 3](#molecules-23-00235-t003){ref-type="table"}).

It is important that this synthesis followed the GAP chemistry (group-assisted-purification chemistry) process, which can avoid traditional recrystallization or column chromatographic purification methods. Pure products were obtained simple by filtration and washing of the solid with a little cold ethanol.

The structures of compounds **4** and **6** were identified from their ^1^H NMR, and ^13^C NMR spectra, and by HRMS analysis. The structure of compound **4a** was further confirmed using single-crystal X-ray diffraction analysis ([Figure 2](#molecules-23-00235-f002){ref-type="fig"}).

Although the detailed mechanism of this reaction remains to be fully clarified, the formation of compound **4** could be explained by the reaction sequence in [Figure 3](#molecules-23-00235-f003){ref-type="fig"}. First, a Knoevenagel condensation of 4-hydroxycoumarin **1** with phenylglyoxal **2** is proposed to give intermediate **A**. Michael addition of enaminone **3** to intermediate **A** then occurs to provide the intermediate **B**, which undergoes isomerization to form the desired product **4**.

3. Experimental {#sec3-molecules-23-00235}
===============

3.1. General {#sec3dot1-molecules-23-00235}
------------

All reagents were commercial and used without further purification, unless otherwise indicated. Melting points were measured using an XT-4 micro melting point apparatus from Beijing Tech Instrument Co., Ltd., Beijing, China and were uncorrected. ^1^H NMR and ^13^C NMR spectra were recorded on Bruker Avance III HD-400 MHz spectrometer from Billerica, MA, USA in DMSO-*d*~6~ solution. *J* values are in hertz (Hz). Chemical shifts are expressed in *δ* downfield from internal tetramethylsilane (TMS). High-resolution mass spectra (HRMS) were obtained using Bruker MicrOTOF-Q II instrument from Billerica, MA, USA. X-ray crystal diffraction analysis was performed with a Bruker APEX-II CCD X-ray diffractometer from Billerica, MA, USA. Microwave irradiation was carried out with Initiator 2.5 Microwave Synthesizers from Biotage, Uppsala, Sweden. The reaction temperatures were measured by an infrared detector (external sensor type) during microwave heating.

3.2. General Procedure for the Synthesis of 3-Functionalized 4-Hydroxycoumarin Derivatives ***4*** and ***6*** {#sec3dot2-molecules-23-00235}
--------------------------------------------------------------------------------------------------------------

4-Hydroxycoumarin (**1**) (0.5 mmol), substituted phenylglyoxal monohydrate (**2**) (0.5 mmol), and 3-arylaminocyclopent-2-enone (**3**) or 4-arylaminofuran-2(5*H*)-one (**5**) (0.5 mmol) were placed in a 10 mL Initiator reaction vial, followed by anhydrous ethanol (2 mL). The reaction vial was then sealed and prestirred for 15 s before being irradiated in the microwave (time, 30 min; temperature, 100 °C; absorption level, high; fixed hold time). The reaction mixture was then cooled to room temperature to give a precipitate, which was collected by Büchner filtration. The solid material was then washed with a little cold ethanol to afford the desired products **4** or **6**.

*4-Hydroxy-3-(2-oxo-1-(5-oxo-2-(p-tolylamino)cyclopent-1-en-1-yl)-2-phenylethyl)-2H-chromen-2-one* (**4a**). White solid, yield 86%, m.p. 134--135 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.26 (s, 1H, OH), 7.78--7.71 (m, 3H, NH + ArH), 7.57--7.23 (m, 11H, ArH), 6.10 (s, 1H, CH), 3.03--2.96 (m, 1H, CH~2~), 2.71--2.64 (m, 1H, CH~2~), 2.47--2.42 (m, 2H, CH~2~), 2.32 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 203.6, 196.4, 176.9, 164.8, 163.6, 152.0, 136.4, 135.5, 132.4, 132.2, 129.8, 128.0, 127.7, 124.0, 123.8, 123.7, 117.6, 115.9, 111.5, 105.0, 40.3, 31.7, 26.7, 20.4. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~22~NO~5~ \[M − H\]^+^ 464.1498. Found: 464.1515.

*3-(1-(2-((4-Bromophenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-oxo-2-(p-tolyl)ethyl)-4-hydroxy-2H-chromen-2-one* (**4b**). Brown solid, yield 90%, m.p. 139--140 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.20 (s, 1H, OH), 7.76--7.67 (m, 3H, NH + ArH), 7.67--7.17 (m, 10H, ArH), 6.09 (s, 1H, CH), 3.09--3.02 (m, 1H, CH~2~), 2.76--2.70 (m, 1H, CH~2~), 2.48--2.38 (m, 2H, CH~2~), 2.25 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 204.5, 195.6, 175.8, 164.3, 163.6, 160.3, 151.9, 142.7, 137.8, 133.6, 132.2, 128.7, 127.9, 125.4, 124.1, 123.8, 118.1, 117.5, 116.0, 112.5, 105.3, 99.5, 31.9, 26.7, 21.0. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~23~BrNO~5~ \[M + H\]^+^ 544.0760. Found: 544.0754.

*3-(1-(2-((4-Chlorophenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-oxo-2-(p-tolyl)ethyl)-4-hydroxy-2H-chromen-2-one* (**4c**). Brown solid, yield 79%, m.p. 142--143 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.22 (s, 1H, OH), 7.77--7.67 (m, 3H, NH + ArH), 7.58--7.17 (m, 10H, ArH), 6.08 (s, 1H, CH), 3.09--3.01 (m, 1H, CH~2~), 2.75--2.69 (m, 1H, CH~2~), 2.47--2.41 (m, 2H, CH~2~), 2.25 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 204.4, 195.7, 175.9, 164.4, 163.6, 151.9, 142.7, 137.4, 133.6, 132.2, 129.9, 129.3, 128.7, 127.9, 125.1, 124.1, 123.8, 117.5, 116.0, 112.5, 105.3, 99.5, 31.9, 30.6, 26.7, 21.0. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~23~ClNO~5~ \[M + H\]^+^ 500.1265. Found: 500.1252.

*3-(1-(2-((4-Bromophenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-(4-methoxyphenyl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**4d**). Green solid, yield 85%, m.p. 222--223 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.18 (s, 1H, OH), 7.77--7.74 (m, 3H, NH + ArH), 7.63--6.91 (m, 10H, ArH), 6.05 (s, 1H, CH), 3.74 (s, 3H, CH~3~O), 3.08--3.02 (m, 1H, CH~2~), 2.77--2.70 (m, 1H, CH~2~), 2.48--2.43 (m, 2H, CH~2~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 204.5, 194.4, 175.7, 164.3, 163.6, 162.5, 152.0, 137.8, 132.2, 130.1, 128.7, 125.3, 124.1, 123.8, 118.0, 117.5, 116.0, 113.4, 112.7, 105.4, 55.3, 32.0, 26.7. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~23~BrNO~6~ \[M + H\]^+^ 560.0709. Found: 560.0706.

*4-Hydroxy-3-(2-(4-methoxyphenyl)-2-oxo-1-(5-oxo-2-(p-tolylamino)cyclopent-1-en-1-yl)ethyl)-2H-chromen-2-one* (**4e**). Blue solid, yield 86%, m.p. 144--146 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.22 (s, 1H, OH), 7.78--7.73 (m, 3H, NH + ArH), 7.58--6.90 (m, 10H, ArH), 6.05 (s, 1H, CH), 3.74 (s, 3H, CH~3~O), 3.01--2.95 (m, 1H, CH~2~), 2.71--2.64 (m, 1H, CH~2~), 2.47--2.37 (m, 2H, CH~2~), 2.41 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 203.7, 194.5, 176.6, 164.7, 163.6, 162.5, 152.0, 135.7, 135.5, 132.1, 130.1, 129.8, 128.9, 124.0, 123.8, 123.7, 117.8, 115.9, 113.3, 111.8, 105.4, 55.3, 31.8, 26.7, 20.5. HRMS (ESI) *m*/*z*: Calcd. for C~30~H~26~NO~6~ \[M + H\]^+^ 496.1760. Found: 496.1757.

*4-Hydroxy-3-(2-(4-methoxyphenyl)-1-(2-((4-methoxyphenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-oxoethyl)-2H-chromen-2-one* (**4f**). Brown solid, yield 81%, m.p. 138--139 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.21 (s, 1H, OH), 7.77--7.72 (m, 3H, NH + ArH), 7.58--6.90 (m, 10H, ArH), 6.03 (s, 1H, CH), 3.77 (s, 3H, CH~3~O) 3.74 (s, 3H, OCH~3~), 2.94--2.88 (m, 1H, CH~2~), 2.65--2.58 (m, 1H, CH~2~), 2.45--2.36 (m, 2H, CH~2~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 207.4, 194.5, 177.2, 164.9, 163.6, 162.5, 157.5, 152.0, 132.1, 130.9, 130.1, 128.8, 125.7, 124.0, 123.8, 117.9, 115.9, 114.5, 113.3, 111.3, 96.9, 55.3, 31.6, 26.7. HRMS (ESI) *m*/*z*: Calcd. for C~30~H~26~NO~7~ \[M + H\]^+^ 512.1709. Found 512.1693.

*3-(1-(2-((4-Bromophenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-(4-chlorophenyl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**4g**). White solid, yield 95%, m.p. 140--141 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.24 (s, 1H, OH), 7.79--7.73 (m, 3H, NH + ArH), 7.64--7.25 (m, 10H, ArH), 6.10 (s, 1H, CH), 3.09--3.02 (m, 1H, CH~2~), 2.77--2.70 (m, 1H, CH~2~), 2.48--2.43 (m, 2H, CH~2~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 204.8, 195.8, 176.5, 165.0, 164.1, 163.0, 152.5, 138.2, 137.8, 135.5, 132.7, 130.0, 128.8, 125.8, 124.3, 118.7, 117.8, 116.5, 113.9, 112.7, 105.3, 55.8, 40.8, 32.4, 27.2. HRMS (ESI) *m*/*z*: Calcd. for C~28~H~20~BrClNO~5~ \[M + H\]^+^ 564.0213. Found: 564.0203.

*3-(2-(4-Chlorophenyl)-2-oxo-1-(5-oxo-2-(p-tolylamino)cyclopent-1-en-1-yl)ethyl)-4-hydroxy-2H-chromen-2-one* (**4h**). Brown solid, yield 72%, m.p. 145--146 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.27 (s, 1H, OH), 7.79--7.72 (m, 3H, NH + ArH), 7.58--7.24 (m, 10H, ArH), 6.10 (s, 1H, CH), 3.02--2.96 (m, 1H, CH~2~), 2.71--2.65 (m, 1H, CH~2~), 2.46--2.39 (m, 2H, CH~2~), 2.31 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 206.2, 195.5, 177.0, 163.5, 152.0, 137.2, 135.6, 135.1, 132.2, 129.8, 129.6, 128.3, 124.0, 123.8, 123.6, 116.0, 111.4, 93.7, 40.3, 31.7, 26.5, 20.5. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~23~ClNO~5~ \[M + H\]^+^ 500.1265. Found 500.1257.

*3-(2-(4-Chlorophenyl)-1-(2-((4-methoxyphenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**4i**). Brown solid, yield 83%, m.p. 140--141 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.29 (s, 1H, OH), 7.79--7.72 (m, 3H, NH + ArH), 7.57--6.99 (m, 10H, ArH), 6.08 (s, 1H, CH), 3.77 (s, 3H, CH~3~O), 2.96--2.90 (m, 1H, CH~2~), 2.66--2.59 (m, 1H, CH~2~), 2.44--2.37 (m, 2H, CH~2~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 203.1, 195.5, 177.5, 165.2, 163.5, 157.6, 152.0, 137.2, 135.1, 132.1, 130.7, 129.5, 128.3, 125.6, 123.9, 123.8, 117.8, 115.9, 114.5, 110.9, 104.6, 55.3, 40.3, 31.6, 26.6. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~23~ClNO~5~ \[M + H\]^+^ 500.1265. Found 500.1257.

*3-(2-(4-Bromophenyl)-1-(2-((4-bromophenyl)amino)-5-oxocyclopent-1-en-1-yl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**4j**). Blue solid, yield 70%, m.p. 159--160 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.24 (s, 1H, OH), 7.76--7.68 (m, 3H, NH + ArH), 7.64--7.25 (m, 10H, ArH), 6.08 (s, 1H, CH), 3.09--3.02 (m, 1H, CH~2~), 2.77--2.71 (m, 1H, CH~2~), 2.47--2.38 (m, 2H, CH~2~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 204.3, 195.5, 176.0, 164.6, 163.5, 152.0, 137.7, 135.4, 132.3, 132.2, 131.3, 129.7, 126.4, 125.3, 124.1,123.8, 118.2, 117.4, 116.0, 112.3, 104.7, 89.6, 40.3, 31.9, 26.7. HRMS (ESI) *m*/*z*: Calcd. for C~28~H~20~Br~2~NO~5~ \[M + H\]^+^ 607.9708. Found 607.9698.

*3-(2-(4-Bromophenyl)-2-oxo-1-(5-oxo-2-(p-tolylamino)cyclopent-1-en-1-yl)ethyl)-4-hydroxy-2H-chromen-2-one* (**4k**). Brown solid, yield 77%, m.p. 161--162 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 10.27 (s, 1H, OH), 7.75--7.69 (m, 3H, NH + ArH), 7.63--7.24 (m, 10H, ArH), 6.09 (s, 1H, CH), 3.02--2.96 (m, 1H, CH~2~), 2.71--2.65 (m, 1H, CH~2~), 2.45--2.38 (m, 2H, CH~2~), 2.31 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 203.5, 195.6, 177.0, 165.0, 163.5, 152.0, 135.6, 135.4, 132.2, 131.2, 139.8, 129.7, 126.3, 124.0,123.8, 123.6, 117.7, 116.0, 111.4, 89.7, 40.3, 31.7, 26.8, 20.5. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~23~BrNO~5~ \[M + H\]^+^ 544.0760. Found 544.0762.

*3-(1-(4-((4-Bromophenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-oxo-2-phenylethyl)-4-hydroxy-2H-chromen-2-one* (**6a**). Pink solid, yield 89%, m.p. 221--223 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.51 (s, 1H, OH), 7.96--7.80 (m, 3H, NH + ArH), 7.62--7.07 (m, 10H, ArH), 5.94 (s, 1H, CH), 5.25 (d, *J* = 15.6Hz, 1H, CH~2~), 5.15 (d, *J* = 16.0 Hz, H, CH~2~). ^13^C NMR (400 MHz, DMSO-*d*~6~) *δ* 195.8, 174.7, 163.4, 162.8, 162.2, 152.0, 138.6, 132.6, 132.3, 128.3, 127.7, 124.2, 123.7, 122.0, 116.4, 116.3, 115.8, 104.3, 94.6, 66.6, 40.4. HRMS (ESI) *m*/*z*: Calcd. for C~27~H~19~BrNO~6~ \[M + H\]^+^ 532.0396. Found 532.0402.

*4-Hydroxy-3-(1-(4-((4-methoxyphenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-oxo-2-phenylethyl)-2H-chromen-2-one* (**6b**). Brown solid, yield 84%, m.p. 116--118 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.29 (s, 1H, OH), 7.93--7.79 (m, 3H, ArH + NH), 7.62--6.91 (m, 11H, ArH), 5.95 (s, 1H, CH), 5.08 (d, *J* = 16.0 Hz, 1H, CH~2~), 4.89 (d, *J* = 16.0 Hz, 1H, CH~2~), 3.73 (s, 3H, CH~3~O). ^13^C NMR (400 MHz, DMSO-*d*~6~) *δ* 196.0, 175.6, 163.7, 163.2, 162.6, 156.5, 151.9, 136.3, 132.4, 131.6, 128.2, 127.6, 124.1, 123.6, 123.2, 116.3, 114.9, 114.6, 104.6, 92.0, 66.5, 55.2, 40.2. HRMS (ESI) *m*/*z*: Calcd. for C~27~H~19~BrNO~6~ \[M + H\]^+^ 484.1396. Found 484.1402.

*3-(2-(4-Chlorophenyl)-2-oxo-1-(2-oxo-4-(p-tolylamino)-2,5-dihydrofuran-3-yl)ethyl)-4-hydroxy-2H-chromen-2-one* (**6c**). White solid, yield 92%, m.p. 219--220 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.30 (s, 1H, OH), 7.97--7.80 (m, 3H, NH + ArH), 7.62--7.03 (m, 10H, ArH), 5.94 (s, 1H, CH), 5.16 (d, 1H, *J* = 15.6 Hz, CH~2~), 5.06 (d, *J* = 16.0 Hz, 1H, CH~2~), 2.25 (s, 3H, CH~3~). ^13^C NMR (400 MHz, DMSO-*d*~6~) *δ* 194.9, 174.8, 163.1, 162.8, 152.0, 137.2, 136.4, 135.1, 133.5, 132.4, 129.9, 129.4, 128.4, 124.1, 123.6, 120.6, 116.3, 104.0, 92.7, 66.5, 56.0, 40.4, 20.3, 18.5. HRMS (ESI) *m*/*z*: Calcd. for C~28~H~21~ClNO~6~ \[M + H\]^+^ 502.1057. Found 502.1068.

*3-(2-(4-Chlorophenyl)-1-(4-((4-chlorophenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**6d**). Pink solid, yield 70%, m.p. 208--210 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.53 (s, 1H, OH), 7.96--7.79 (m, 3H, NH + ArH), 7.62--7.12 (m, 10H, ArH), 5.87 (s, 1H, CH), 5.21 (d, *J* = 16.0 Hz, 1H, CH~2~), 5.12 (d, *J* = 16.0 Hz, 1H, CH~2~). ^13^C NMR (400 MHz, DMSO-*d*~6~) *δ* 194.8, 174.3, 163.1, 162.1, 152.1, 138.1, 137.2, 135.1, 132.4, 129.4, 128.4, 127.7, 124.1, 123.6, 121.7, 116.4, 103.7, 94.2, 66.4, 40.2. HRMS (ESI) *m*/*z*: Calcd. for C~27~H~18~Cl~2~NO~6~ \[M + H\]^+^ 522.0521. Found 522.0523.

*3-(1-(4-((4-Bromophenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-(4-chlorophenyl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**6e**). Pink solid, yield 91%, m.p. 190--191 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.46 (s, 1H, OH), 7.97--7.80 (m, 3H, NH + ArH), 7.62--7.08 (m, 10H, ArH), 5.91 (s, 1H, CH), 5.24 (d, *J* = 16.0 Hz, 1H, CH~2~), 5.14 (d, *J* = 16.0 Hz, 1H, CH~2~). ^13^C NMR (400 MHz, DMSO-*d*~6~) *δ* 195.2, 174.8, 163.8, 163.3, 162.6, 152.5, 139.0, 137.8, 135.5, 132.8, 132.6, 129.9, 128.9, 124.6, 124.1, 122.5, 116.8, 116.2, 104.3, 94.8, 67.0, 19.0. HRMS (ESI) *m*/*z*: Calcd. for C~27~H~18~BrClNO~6~ \[M + H\]^+^ 566.0006. Found 566.0026.

*3-(2-(4-Bromophenyl)-2-oxo-1-(2-oxo-4-(p-tolylamino)-2,5-dihydrofuran-3-yl)ethyl)-4-hydroxy-2H-chromen-2-one* (**6f**). Pink solid, yield 91%, m.p. 218--219 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.31 (s, 1H, OH), 7.96--7.71 (m, 3H, NH + ArH), 7.65--7.02 (m, 10H, ArH), 5.91 (s, 1H, CH), 5.15 (d, *J* = 16.0 Hz, 1H, CH~2~), 5.05 (d, *J* = 16.0 Hz, 1H, CH~2~), 5.25 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 195.2, 174.7, 163.1, 162.9, 152.0, 136.4, 135.5, 133.4, 132.4, 131.3, 129.9, 129.5, 126.3, 124.1, 123.6, 120.6, 116.4, 103.9, 92.7, 66.4, 20.3, 18.5. HRMS (ESI) *m*/*z*: Calcd. for C~28~H~21~BrNO~6~ \[M + H\]^+^ 546.0552. Found 546.0543.

*3-(2-(4-Bromophenyl)-1-(4-((4-methoxyphenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**6g**). White solid, yield 77%, m.p. 155--157 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.27 (s, 1H, OH), 7.93--7.70 (m, 3H, NH + ArH), 7.73--6.90 (m, 10H, ArH), 5.86(s, 1H, CH), 5.05 (d, *J* = 15.6 Hz, 1H, CH~2~), 4.95 (d, *J* = 16.0 Hz, 1H, CH~2~), 3.73 (s, 3H, CH~3~). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 195.1, 175.2, 163.7, 163.1, 162.6, 156.5, 152.0, 135.5, 132.4, 131.6, 131.3, 129.5, 126.4, 124.1, 123.6, 123.2, 116.3, 114.6, 104.2, 91.7, 66.3, 55.2, 40.7. HRMS (ESI) *m*/*z*: Calcd. for C~28~H~21~BrNO~7~ \[M + H\]^+^ 562.0501. Found 562.0493.

*4-Hydroxy-3-(2-(4-methoxyphenyl)-1-(4-((4-methoxyphenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-oxoethyl)-2H-chromen-2-one* (**6h**). White solid, yield 91%, m.p. 170--172 °C. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.28 (s, 1H, OH), 7.94--7.77 (m, 3H, NH + ArH), 7.63--6.91 (m, 10 H, ArH), 5.92(s, 1H, CH), 5.19 (d, *J* = 15.6 Hz, 1H, CH~2~), 4.97 (d, *J* = 15.6 Hz, 1H, CH~2~), 3.76 (s, 3H, CH~3~O), 3.73 (s, 3H, CH~3~O). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 194.3, 176.0, 163.7, 163.3, 162.6, 156.5, 151.9, 132.4, 131.6, 129.9, 128.7, 124.1, 123.6, 123.1, 116.3, 114.6, 113.5, 105.0, 92.4, 66.6, 55.2, 39.7. HRMS (ESI) *m*/*z*: Calcd. for C~29~H~24~NO~8~ \[M + H\]^+^ 514.1502. Found 514.1495.

*3-(1-(4-((4-Chlorophenyl)amino)-2-oxo-2,5-dihydrofuran-3-yl)-2-(4-methoxyphenyl)-2-oxoethyl)-4-hydroxy-2H-chromen-2-one* (**6i**). Brown solid, yield 72%, m.p. 206--207. ^1^H NMR (400 MHz, DMSO-*d*~6~) *δ* 9.48 (s, 1H, OH), 7.97--7.78 (m, 3H, NH + ArH), 7.61--6.94 (m, 10H, ArH), 5.93 (s, 1H, CH), 5.25 (d, *J* = 16.0 Hz, 1H, CH~2~), 5.14 (d, *J* = 16.0 Hz, 1H, CH~2~), 3.76 (s, 3H, CH~3~O). ^13^C NMR (100 MHz, DMSO-*d*~6~) *δ* 194.1, 174.9, 163.4, 162.6, 162.1, 152.0, 138.2, 132.4, 129.9, 129.4, 128.7, 127.6, 124.1, 123.6, 121.5, 116.3, 113.5, 104.4, 94.8, 66.6, 55.3, 40.0. HRMS (ESI) *m*/*z*: Calcd. for C~28~H~21~ClNO~7~ \[M + H\]^+^ 518.1007. Found 518.1018.

4. Conclusions {#sec4-molecules-23-00235}
==============

In summary, we have developed a novel, highly efficient, catalyst-free, green protocol for the one-pot three-component synthesis of 3-functionalized 4-hydroxycoumarin derivatives. This protocol has the advantages of mild reaction conditions, high yields, convenient operation, and environmental friendliness.
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###### 

Optimization of the reaction conditions.

![](molecules-23-00235-i001)

  Entry   Catalyst (mol %)    Solvent (*v*/*v*)   Temperature (°C)                Time (min)   Yield (%) ^a^
  ------- ------------------- ------------------- ------------------------------- ------------ ---------------
  1       No                  EtOH                100                             30           89
  2       No                  H~2~O               100                             30           36
  3       No                  DMF                 100                             30           70
  4       No                  CH~3~CN             100                             30           80
  5       No                  EtOH-H~2~O (1:1)    100                             30           54
  6       No                  EtOH:H~2~O (3:1)    100                             30           72
  7       NaOH (20)           EtOH                100                             30           33
  8       Et~2~NH (20)        EtOH                100                             30           50
  9       *p*-TSA (20)        EtOH                100                             30           80
  10      Benzoic Acid (20)   EtOH                100                             30           51
  11      *L*-Proline (20)    EtOH                100                             30           81
  12      No                  EtOH                80                              30           69
  13      No                  EtOH                90                              30           76
  14      No                  EtOH                110                             30           87
  15      No                  EtOH                100                             10           57
  16      No                  EtOH                100                             20           65
  17      No                  EtOH                100                             40           86
  18      No                  EtOH                Reflux (absence of microwave)   240          60

^a^ Yield was determined by HPLC-MS.
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###### 

Synthesis of 3-functionalized 4-hydroxycoumarin derivatives **4**.

![](molecules-23-00235-i002)

  Entry   R^1^     R^2^     Product   Isolated Yield (%)
  ------- -------- -------- --------- --------------------
  1       H        CH~3~    **4a**    86
  2       CH~3~    Br       **4b**    90
  3       CH~3~    Cl       **4c**    79
  4       CH~3~O   Br       **4d**    85
  5       CH~3~O   CH~3~    **4e**    86
  6       CH~3~O   CH~3~O   **4f**    81
  7       Cl       Br       **4g**    95
  8       Cl       CH~3~    **4h**    72
  9       Cl       CH~3~O   **4i**    83
  10      Br       Br       **4j**    70
  11      Br       CH~3~    **4k**    77
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###### 

Synthesis of 3-functionalized 4-hydroxycoumarin derivatives **6**.

![](molecules-23-00235-i003)

  Entry   R^1^     R^2^     Product   Isolated Yield (%)
  ------- -------- -------- --------- --------------------
  1       H        Br       **6a**    89
  2       H        CH~3~O   **6b**    84
  3       Cl       CH~3~    **6c**    92
  4       Cl       Cl       **6d**    70
  5       Cl       Br       **6e**    91
  6       Br       CH~3~    **6f**    91
  7       Br       CH~3~O   **6g**    77
  8       CH~3~O   CH~3~O   **6h**    91
  9       CH~3~O   Cl       **6i**    72
